Eli Lilly (NYSE: LLY)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Eli Lilly Return vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Eli Lilly Company Info
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
News & Analysis
One of these dividend-paying pharma stocks is a markedly better passive income vehicle.
There's no rule that says a market must have only one winner.
It's a lot more likely than it might sound at first.
The biotech's prospects continue to get brighter.
Eli Lilly stock may look expensive, but there's still plenty of value here for long-term investors.
Investors are excited about several candidates in the drug company's pipeline.
The pharmaceutical giant is likely to grow quickly as it is entering a new age of contested markets.
There are quite a few details to keep track of with this company, and they all matter.
LLY earnings call for the period ending March 31, 2023.
LLY earnings call for the period ending December 31, 2022.
LLY earnings call for the period ending September 30, 2022.
LLY earnings call for the period ending June 30, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.